Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EMPOWER-1: A Multi-site Clinical Cohort Study to Reduce Health Inequality: Identifying Ethnic Disparities in Treatment Failures for Medicines Prescribed to Treat Diseases That Cause Significant Mortality and Morbidity in the UK Population

NCT03987633 is registered in ClinicalTrials.gov with Future Genetics Limited as lead sponsor.

NCT NCT03987633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03987633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EMPOWER-1: A Multi-site Clinical Cohort Study to Reduce Health Inequality: Identifying Ethnic Disparities in Treatment Failures for Medicines Prescribed to Treat Diseases That Cause Significant Mortality and Morbidity in the UK Population
Lead sponsor
Future Genetics Limited
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2020
Completion date
February 1, 2030
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, atrial fibrillation, blood pressure, breast cancer risk, cancer, cardiovascular diseases, chronic kidney diseases, chronic obstructive pulmonary disease, coronary heart disease, dementia, depression, diabetes mellitus, epilepsy, heart failure, hypertension, lung cancers, mental health disorder, obesity, peripheral arterial disease, prostate cancer, rheumatoid arthritis, stroke, ischemic